The verdict is the latest twist in patent litigation between MSD and Halozyme, in which the latter is claiming that Keytruda ...
Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, ...
Merck & Co (MSD) has announced that it is discontinuing two Phase III Keytruda (pembrolizumab) clinical trials. The KEYNOTE-867 (NCT03924869) trial was evaluating Keytruda plus stereotactic body ...
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
For five months starting in late 2013, Yvette Downs began her work week at Cincinnati's Metropolitan Sewer District by boarding a plane in Washington, D.C. Downs, who was MSD’s senior financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback